Atypical endoscopic findings required surgical resection and histopathological confirmation, after which the patient responded well to a Crohn disease exclusion diet and maintenance infliximab.
JPGN Reports · 5 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Atypical endoscopic findings required surgical resection and histopathological confirmation, after which the patient responded well to a Crohn disease exclusion diet and maintenance infliximab.
This case report describes a 13-year-old girl with genetically confirmed BBS7 who presented with weekly periumbilical abdominal pain, significant weight loss of 5.5 kg over 3 months, and stunted growth. Laboratory testing showed elevated C-reactive protein (95 mg/L), low albumin, and elevated fecal calprotectin (>6000 µg/g). Neither gastroscopy nor colonoscopy revealed macroscopic abnormalities, but abdominal ultrasound and MRI identified two stenotic segments of the terminal ileum with prestenotic dilatation. Histology of ileal biopsies showed mild inflammation with microgranulomas. Surgical resection was performed due to infliximab contraindication from latent tuberculosis, and histopathology of the resection specimen confirmed Crohn disease. Maintenance infliximab with methotrexate was initiated 6 months after surgery. This case highlights that IBD prevalence is significantly higher in BBS patients (1.51%) than the general population (0.40%), with an odds ratio of 3.83. The atypical presentation underscores the need for a low threshold for IBD diagnostic testing in BBS patients with gastrointestinal symptoms.